Status:
TERMINATED
Determination of Rates and Reasons for Non-Adherence to Anti-Arrhythmic Therapy for Atrial Fibrillation
Lead Sponsor:
Creighton University
Collaborating Sponsors:
Sanofi
Conditions:
Atrial Fibrillation
Medication Adherence
Eligibility:
All Genders
19+ years
Phase:
PHASE4
Brief Summary
The purpose of this study is to determine if follow-up by a pharmacist over the telephone improves adherence and short term clinical outcomes in the patient with atrial fibrillation prescribed an oral...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Prescribed a new anti-arrhythmic medication for atrial fibrillation
Exclusion
Key Trial Info
Start Date :
January 1 2012
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 1 2012
Estimated Enrollment :
9 Patients enrolled
Trial Details
Trial ID
NCT01513031
Start Date
January 1 2012
End Date
June 1 2012
Last Update
July 2 2012
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
Bryan LGH
Lincoln, Nebraska, United States, 68506
2
Alegent Health Bergan Mercy Medical Center
Omaha, Nebraska, United States, 68124
3
Creighton University
Omaha, Nebraska, United States, 68178